Futaba Corporation (6986.T)
Mobara, JP
Operating across Japan, the Americas, Europe, and Asia, Futaba Corporation specializes in the creation, production, and distribution of electronic devices, radio-controlled apparatus, and various manufacturing machinery. Its operations are organized into two primary divisions: Electronic Devices, and Machinery and Tooling. Within the Electronic Devices segment, Futaba offers a diverse range of products, including OLED, USB, and LCD display modules, along with other electronic modules and touch panels. It also supplies radio control systems for both industrial applications and hobbyists, as well as engines and components tailored for models and robotics. The Machinery and Tooling division focuses on providing essential components for press die sets and plastic molding, such as mold bases and precision plates. This segment further delivers advanced in-cavity measuring systems, automation solutions, touch sensors, and equipment designed to streamline molding processes. Established in 1948, Futaba Corporation's corporate headquarters are situated in Mobara, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.20% | -11.51% | -3.78% | -9.95% | -3.78% | +11.66% | +27.12% | +25.67% | -23.67% | -60.16% | -81.27% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Hardware, Equipment & Parts: +10.0%-10.7% Q1'26: -5.1% (vs Q1'25)
-
EPS growth Hardware, Equipment & Parts: +20.2%+998.2% ★ Q1'26: +232.8% (vs Q1'25)
-
FCF margin FCF growth · Hardware, Equipment & Parts: +27.1%-1.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Hardware, Equipment & Parts: +8.7%-5.3% Q1'26: -6.6% (vs Q1'25)
-
ROIC Hardware, Equipment & Parts: +5.7%-3.4% Q1'26: -4.6% (vs Q1'25)
-
Share dilution Hardware, Equipment & Parts: +0.0%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Hardware, Equipment & Parts: -0.70×-0.39× Q1'26: -0.25× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
70.14B
est: 70.20B (-0.1%)
|
69.83B
est: 70.00B (-0.2%)
|
64.16B
est: 63.60B (+0.9%)
|
69.35B
est: 70.00B (-0.9%)
|
67.08B
est: 67.30B (-0.3%)
|
57.21B
est: 58.00B (-1.4%)
|
48.83B
est: 58.10B (-16.0%)
|
53.45B
est: 60.50B (-11.7%)
|
60.33B
est: 77.80B (-22.5%)
|
| EBITDA |
5.95B
est: -568.62M (+1,145.9%)
|
5.44B
est: -567.00M (+1,059.4%)
|
2.90B
est: -515.16M (+662.0%)
|
4.28B
est: -567.00M (+854.8%)
|
3.83B
est: -545.13M (+803.1%)
|
-1.95B
est: -469.80M (-315.7%)
|
-2.25B
est: -470.61M (-377.9%)
|
-661.00M
est: -490.05M (-34.9%)
|
-1.12B
est: -630.18M (-77.4%)
|
| EBIT |
1.90B
est: -2.17B (+187.5%)
|
1.49B
est: -2.17B (+168.9%)
|
-383.00M
est: -1.97B (+80.5%)
|
726.00M
est: -2.17B (+133.5%)
|
324.00M
est: -2.08B (+115.6%)
|
-3.70B
est: -1.79B (-106.1%)
|
-3.52B
est: -1.80B (-95.7%)
|
-1.86B
est: -1.87B (+0.4%)
|
-2.39B
est: -2.41B (+0.9%)
|
| Net Income |
567.00M
est: 1.82B (-68.8%)
|
-1.95B
est: 517.48M (-476.1%)
|
-2.37B
est: -2.10B (-12.9%)
|
1.18B
est: 1.48B (-20.4%)
|
-16.02B
est: -1.30B (-1,133.9%)
|
-10.12B
est: -7.60B (-33.1%)
|
-5.43B
est: 50.90M (-10,766.2%)
|
-2.67B
est: 441.13M (-704.6%)
|
-3.50B
|
| SGA |
10.47B
est: 14.05B (-25.5%)
|
10.68B
est: 14.01B (-23.8%)
|
10.63B
est: 12.73B (-16.5%)
|
11.61B
est: 14.01B (-17.2%)
|
11.19B
est: 13.47B (-17.0%)
|
10.67B
est: 11.61B (-8.1%)
|
9.07B
est: 11.63B (-22.0%)
|
8.92B
est: 12.11B (-26.4%)
|
9.40B
est: 15.57B (-39.6%)
|
| EPS |
12.76
est: 42.80 (-70.2%)
|
-44.74
est: 12.20 (-466.7%)
|
-55.84
est: -49.50 (-12.8%)
|
27.79
est: 34.90 (-20.4%)
|
-377.54
est: -30.60 (-1,133.8%)
|
-238.58
est: -179.20 (-33.1%)
|
-128.01
est: 1.20 (-10,767.5%)
|
-62.90
est: 10.40 (-704.8%)
|
-82.49
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 49.3K | 0.40% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 585.3K | 0.06% |
| 3 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 8.5K | 0.30% |
| 4 | iShares Core TOPIX ETF 1475.T | 0.00% | 373.4K | 0.05% |
| 5 | Vanguard FTSE Pacific ETF VPL | 0.00% | 179.2K | 0.07% |
| 6 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 1.7K | 0.22% |
| 7 | Vanguard FTSE Developed All Cap ex U.S. Index ETF (CAD-hedged) VEF.TO | 0.00% | 4.1K | 0.22% |
| 8 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 2.7K | 0.22% |
| 9 | Vanguard FTSE Developed All Cap ex North America Index ETF VIU.TO | 0.00% | 34.4K | 0.23% |
| 10 | Vanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged) VI.TO | 0.00% | 3.0K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Masaharu Tomita | Managing Executive Officer & Director | — | — |
| Motoaki Arima | Chief Executive Officer, President & Representative Director | — | male |
| Toshihide Kimizuka | Senior Managing Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6986.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
